- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 15/90 - Stable introduction of foreign DNA into chromosome
Patent holdings for IPC class C12N 15/90
Total number of patents in this class: 7373
10-year publication summary
|
349
|
481
|
609
|
678
|
625
|
782
|
817
|
795
|
700
|
339
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 20669 |
296 |
| President and Fellows of Harvard College | 6076 |
214 |
| Massachusetts Institute of Technology | 10228 |
206 |
| The Broad Institute, Inc. | 1963 |
197 |
| Regeneron Pharmaceuticals, Inc. | 4688 |
193 |
| Sangamo Therapeutics, Inc. | 385 |
119 |
| The Board of Trustees of the Leland Stanford Junior University | 6633 |
114 |
| CRISPR Therapeutics AG | 366 |
98 |
| University of Vienna | 112 |
88 |
| Cellectis | 415 |
83 |
| The General Hospital Corporation | 4849 |
74 |
| Arbor Biotechnologies Inc. | 167 |
66 |
| EmendoBio Inc. | 153 |
64 |
| Inscripta, Inc., FORMERLY Muse Biotechnology, Inc. | 270 |
63 |
| Caribou Biosciences, Inc. | 161 |
62 |
| University of Massachusetts | 2304 |
59 |
| Emmanuelle Charpentier | 59 |
59 |
| Editas Medicine, Inc. | 250 |
56 |
| Beam Therapeutics Inc. | 284 |
54 |
| Flagship Pioneering Innovations VI, LLC. | 588 |
52 |
| Other owners | 5156 |